Byakangelicol
Product Specifications
CAS Number
26091-79-2
Target
COX
Related Pathways
Neuroscience|||Immunology/Inflammation
Purity
0.9955
Bioactivity
1. Byakangelicol may inhibit P-gp expressed at the BBB even under in vivo conditions. 2. Byakangelicol can inhibit IL-1beta-induced PGE2 release in A549 cells; this inhibition may be mediated by suppression of COX-2 expression and the activity of COX-2 enzyme, thus it may have therapeutic potential as an anti-inflammatory drug on airway inflammation.
Smiles
[H][C@]1(COc2c3occc3c(OC)c3ccc(=O)oc23)OC1(C)C
Molecular Formula
C17H16O6
Molecular Weight
316.31
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
RC221789L4 10 µg
IL28 Receptor alpha (IFNLR1) (NM_173065) Human Tagged Lenti ORF Clone
Ask
View Details 
